Zehao Cai
2024–2024 OpenAlex profile ↗
Reproducibility track record
1
assessed papers
73/100
mean reproducibility
0
reproduced (C1–C2)
0
flagged
8
total citations
flag rate:
0%
(0/1)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 0
last author: 0
Topics
Funders
—
Frequent co-authors
Institutions
Capital Medical University 1Beijing Tian Tan Hospital 1Aerospace Center Hospital 1
Geography (author institutions)
CN 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (1)
Complete publication record (32)
Request a reproduction →1 assessed by us (0 reproduced) · 31 not yet assessed — every PubMed paper on record, linked below.
-
Prognostic of Baseline 18 F-FDG PET Parameters in Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Meta-Analysis ↗SSRN Electronic Journal · 2026not yet assessed
-
Initiation timing and treatment duration of eltrombopag added to immunosuppressive therapy in aplastic anemia: a systematic review and meta-analysis ↗Frontiers in Oncology · 2026not yet assessed
-
ScRNA-seq unveils the functional characteristics of glioma-associated macrophages and the regulatory effects of chlorogenic acid on the immune microenvironment—a study based on mouse models and clinical practice ↗Frontiers in Immunology · 2025 · PMID 39867913not yet assessed
-
not yet assessed
-
ARL3 Enhances ERα Stability via USP10 Deubiquitination to Promote Endocrine Resistance and Drive Mitochondrial Metabolic Reprogramming in HR+ Breast Cancer ↗Advanced Science · 2025 · PMID 41047477not yet assessed
-
not yet assessed
-
Abstract P5-10-25: Exploring JAM2's Potential in Reducing Breast Cancer Invasiveness through IGF2BP2 Regulation ↗Clinical Cancer Research · 2025not yet assessed
-
Abstract P2-04-10: ARL3 Promotes Hormone Receptor Positive Breast Cancer Progression and Tamoxifen Resistance through ERα Stablization ↗Clinical Cancer Research · 2025not yet assessed
-
This Meta-Analysis Evaluates the Optimal Timing for Initiating and Discontinuing Eltrombopag for Aplastic Anemia ↗Research Square · 2025not yet assessed
-
not yet assessed
-
Integrated multiomic analysis reveals disulfidptosis subtypes in glioblastoma: implications for immunotherapy, targeted therapy, and chemotherapyFrontiers in Immunology · 2024 · PMID 38504986L1 73/100
-
Targeting tumour surface collage with hydrogel probe: a new strategy to enhance intraoperative imaging sensitivity and stability of bladder cancer ↗European Journal of Nuclear Medicine and Molecular Imaging · 2024 · PMID 39060372not yet assessed
-
UTRN as a potential biomarker in breast cancer: a comprehensive bioinformatics and in vitro study ↗Scientific Reports · 2024 · PMID 38565593not yet assessed
-
Tumor treating induced fields: a new treatment option for patients with glioblastoma ↗Frontiers in Neurology · 2024 · PMID 39484048not yet assessed
-
not yet assessed
-
Honokiol in glioblastoma recurrence: a case report ↗Frontiers in Neurology · 2023 · PMID 37426439not yet assessed
-
Abstract CT113: Safety and efficacy of Tumor Treating Fields (TTFields) combined with bevacizumab and systemic chemotherapy in recurrent GBM ↗Cancer Research · 2023not yet assessed
-
Is extremely low frequency pulsed electromagnetic fields applicable to gliomas? A literature review of the underlying mechanisms and application of extremely low frequency pulsed electromagnetic fields ↗Cancer Medicine · 2022 · PMID 35929424not yet assessed
-
Molecular profile reveals immune-associated markers of medulloblastoma for different subtypes ↗Frontiers in Immunology · 2022 · PMID 35967388not yet assessed
-
A Novel Classification of Glioma Subgroup, Which Is Highly Correlated With the Clinical Characteristics and Tumor Tissue Characteristics, Based on the Expression Levels of Gβ and Gγ Genes ↗Frontiers in Oncology · 2021 · PMID 34222011not yet assessed
-
MicroRNAs as Diagnostic Biomarkers in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis ↗Frontiers in Oncology · 2021 · PMID 34604087not yet assessed
-
Molecular profile reveals immune-associated markers of medulloblastoma for different subtypes ↗Research Square · 2021not yet assessed
-
Molecular profile reveals immune-associated markers of medulloblastoma for different subtypes ↗Research Square · 2021not yet assessed
-
MicroRNAs as diagnostic biomarkers in primary central nervous system lymphoma: a systematic review and meta-analysis ↗Research Square · 2021not yet assessed
-
Viral infection and glioma: a meta-analysis of prognosis ↗BMC Cancer · 2020 · PMID 32532243not yet assessed
-
Social Policy Responses to the Covid-19 Crisis in China in 2020 ↗International Journal of Environmental Research and Public Health · 2020 · PMID 32823833not yet assessed
-
Viral infection and glioma: a meta-analysis of prognosis. ↗Research Square · 2020not yet assessed
-
Viral infection and glioma: a meta-analysis of prognosis ↗Research Square · 2020not yet assessed
-
Viral infection and glioma: a meta-analysis of prognosis ↗Research Square · 2019not yet assessed
-
皮革涂饰废水处理工程设计与低温启动调试DOAJ (DOAJ: Directory of Open Access Journals) · 2015not yet assessed
-
[The experimental study of creating a new rat scarring model by inserting absorbable gelatin sponge into rats' excisional wounds]. ↗PubMed · 2008 · PMID 18437984not yet assessed
-
Trauma and pulmonary thromboembolism: an experimental study on their correlation. ↗PubMed · 2007 · PMID 17651594not yet assessed
Full bibliography from OpenAlex; reproducibility verdicts matched by PMID.
Author attribution follows OpenAlex disambiguation, which is imperfect — a researcher's papers can be split across profiles or mixed with a namesake.
No ORCID on record to anchor it (≈⅓ of researchers have none), so this rests on name disambiguation alone. See every “Cai Z” paper on PubMed ↗